In Vitro Anticancer Activity of Hexane and Ethyl acetate Extracts of Leaf, Petiole and Rhizome of Petasites japonicus http://www.doi.org/10.26538/tjnpr/v7i1.18
Article Sidebar
Main Article Content
Abstract
The aim of this study was to ascertain the effect of different solvents on extraction yield, antioxidant activity and cytotoxicity of extracts from Petasites japonicus (Siebold & Zucc.) Maxim. P. japonicus, widely distributed in Korea, Japan and China, is used as a culinary vegetable and a traditional medicine for asthma, migraines and tension headaches, and allergic rhinitis. In this study, twelve extracts from leaves, petioles and rhizomes of P. japonicus were evaluated for their antiproliferative activity against AGS, HepG2, HCT-116, and MCF-7 cancer cell lines. Plant extracts were fractionated using hexane, EtOAc, BuOH and distilled water, after which the antiproliferative activity was measured by MTT assay. Cell viability decreased in a dose dependent manner in response to the hexane and ethyl acetate extracts for all cell lines, with a significant decrease in cell viability being observed for 100 μg/ml and 75 μg/ml in the AGS and HepG2 cancer cell lines (p < 0.05). The leaf extract appeared to be more potent against HepG2, as indicated by IC50 values of 4.31 μg/ml for approximately 2.5- and 6.3-fold compared with rhizome and petiole extracts, respectively. The IC50 values of hexane extracts from leaves and rhizomes against AGS, HepG2, and MCF-7 human cell lines were greater than those of other extracts, while ethyl acetate extracts from petioles showed higher significant effect for all cell lines. Hexane and EtOAc extracts exerted their antiproliferative activity in four cancer cell lines. Overall, the results indicate that P. japonicus has the potential to be developed into selective anticancer nutraceutical and/or pharmaceutical treatments with low cost.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Debrenner B, Meier B. Petasites hybridus: a tool for interdisciplinary research in phytotherapy. Pharm Acta Helv. 1998; 72:359-380.
Hiemori-Kondo M. Antioxidant compounds of Petasites japonicus and their preventive effects in chronic diseases: a review. J Clin Biochem Nutr. 2020; 67(1):10-18.
Borlak J, Diener H-C, Kleeberg-Hartmann J, Messlinger K, Silberstein S. Petasites for migraine prevention: New data on mode of action, pharmacology and safety. A narrative review. Front Neurol. 2022; 13:864689.
Guo L, Li K, Cui ZW, Kang JS, Son BG, Choi YW. S-petasin isolated from Petasites japonicus exerts anti-adipogenic activity in the 3T3-L1 cell line by inhibiting PPAR-γ pathway signaling. Food Funct. 2019; 10(7):4396-4406.
Lee JS, Jeong M, Park S, Ryu SM, Lee J, Song Z, Guo Y, Choi J-H, Lee D, Jang DS. Chemical constituents of the leaves of butterbur (Petasites japonicus) and their antiinflammatory effects. Biomolecules 2019; 9:806.
Guo L, Kang JS, Kang NJ, Choi YW. S-petasin induces apoptosis and inhibits cell migration through activation of p53 pathway signaling in melanoma B16F10 cells and A375 cells. Arch Biochem Biophys. 2020; 692:108519.
Kulinowski Ł, Luca SV, Minceva M, Skalicka-Wo´zniak K. A review on the ethnobotany, phytochemistry, pharmacology and toxicology of butterbur species (Petasites L.). J Ethnopharmacol. 2022; 293:115263.
Kitajima M, Okabe K, Yoshida M, Nakabayashi R, Saito K, Kogure N, Takayama H. New otonecine-type pyrrolizidine alkaloid from Petasites japonicus. J Nat Med. 2019; 73:602–607.
Mihajilov-Krstev T, Jovanović B, Zlatković B, Matejić J, Vitorović J, Cvetković V, Ilić B, Đorđević L, Joković N, Miladinović D, Jakšić T, Stanković N, Jovanović VS, Bernstein N. Phytochemistry, Toxicology and Therapeutic Value of Petasites hybridus Subsp. Ochroleucus (Common Butterbur) from the Balkans. Plants (Basel). 2020; 9(6):700 (1-15).
Getasetegn M, Tefera Y. Biological activities and valuable compounds from five medicinal plants. Nat Prod Chem Res. 2016; 4(4):1000220.
Paulpriya K. Phytochemical and bioactive potential of Melastoma malabathricum: an important medicinal herb. In: Ethnomedicinal plants with therapeutic properties. (Mohan VR, Doss A, Tresina PS. eds) Apple Academic Press: New York; 2019;149-164.
Abdulqawi LNA, Quadri A, Islam S, Santra MK, Farooqui M. Chemical compositions and anticancer activity of Yemeni plant Flemingia grahamiana Wight & Arn. and Myrtus communis L. Trop J Nat Prod Res. 2021; 5(5):877-882.
Huang M, Lu J-J, Ding J. Natural products in cancer therapy: Past, present and future. Nat Prod Bioprospect. 2021; 11:5-13.
Ogbeide OK, Dickson VO, Jebba RD, Owhiroro DA, Olaoluwa MO, Imieje VO, Erharuyi O, Owolabi BJ, Fasinu PS, Falodun A. Antiplasmodial and acute toxicity studies of fractions and cassane-type diterpenoids from the stem bark of Caesalpinia pulcherrima (L.) Sw. Trop J Nat Prod Res. 2018; 2(4):179-184.
Wall ME. 1998. Camptothecin and taxol: discovery to clinic. Med Res Rev. 1998; 18(5):299-314.
Rayan A, Raiyn J, Falah M. Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. PLoS ONE 2017; 12(11):e0187925.
Ganur ANA, Kurniawanti K, Sugita P, Ambarsari L, Syahbirin G, Ilmiawati A, Rahayu DUC. Identified compounds from ethyl acetate phase of Temu Mangga(Curcuma mangga Val.) using LC-MS/MS and their potential as anticancer against MCF-7 cells. Trop J Nat Prod Res. 2022; 6(12):1941-1946.
Atanasov AG, Zotchev SB, Dirsch VM, International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021; 20:200-216.
Yuan M, Zhang G, Bai W, Han X, Li C, Bian S. The Role of bioactive compounds in natural products extracted from plants in cancer treatment and their mechanisms related to anticancer effects. Oxid Med Cell Longev. 2022; 2022:1429869.
Garcia-Oliveira P, Otero P, Pereira AG, Chamorro F, Carpena M, Echave J, Fraga-Corral M, Simal-Gandara J, Prieto MA. Status and challenges of plant-anticancer compounds in cancer treatment. Pharmaceut. 2021; 14:157 (1-28).
Huyke C, Engel K, Simon B, Quirin K, Schempp C. Composition and biological activity of different extracts from Schisandra sphenanthera and Schisandra chinensis. Planta Med. 2007; 73:1116-1126.
Lai C, Mas R, Nair N, Majid M, Mansor S, Navaratnam V. Typhonium flagelliforme inhibits cancer cell growth in vitro and induces apoptosis: an evaluation by the bioactivity guided approach. J. Ethnopharmacol. 2008; 118:14-20.
Afsar T, Razak S, Khan MR, Mawash S, Almajwal A, Shabir M, Haq IU. Evaluation of antioxidant, anti-hemolytic and anticancer activity of various solvent extracts of Acacia hydaspica R. Parker aerial parts. BMC Complement Altern Med. 2016; 16:258 (1-16).
Antje B, Kunert O, Haslinger E, Bauer R. New eremophilane sesquiterpenes from a rhizome extract of Petasites hybridus. Helvetica Chimica Acta 2007; 90:183-195.
Wang YL, Li RP, Guo ML, Zhang G, Zhang N, Ma YL. Bakkenolides from Petasites tricholobus and their neuroprotective effects related to antioxidant activities. Planta Med. 2009; 75:230-235.
Choi YW, Lee K-P, Kim J-M, Kang S, Park S-J, Lee J-M, Moon HR, Jung JH, Lee Y-G, Im DS. Petatewalide B, a novel compound from Petasites japonicus with anti-allergic activity. J Ethnopharmacol. 2016; 178:17-24.
Itharat A, Houghton PJ, Eno-Amooquaye E, Burke PJ, Sampson JH, Raman A. In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer. J Ethnopharmacol. 2004; 90:33–38.